Cargando…
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a treatment-limiting and debilitating neurotoxicity of many commonly used anti-cancer agents, including paclitaxel. The objective of this study was to confirm the previously found inverse association between pre-treatment blood concent...
Autores principales: | Chen, Ciao-Sin, Zirpoli, Gary, Thomas Budd, G., Barlow, William E., Pusztai, Lajos, Hortobagyi, Gabriel N., Albain, Kathy S., Godwin, Andrew K., Thompson, Alastair, Lynn Henry, N., Ambrosone, Christine B., Stringer, Kathleen A., Hertz, Daniel L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491324/ https://www.ncbi.nlm.nih.gov/pubmed/37693586 http://dx.doi.org/10.21203/rs.3.rs-3242513/v1 |
Ejemplares similares
-
Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
por: Yao, Song, et al.
Publicado: (2013) -
Supplement use during an intergroup clinical trial for breast cancer (S0221)
por: Zirpoli, Gary R., et al.
Publicado: (2013) -
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
por: Mongiovi, Jennifer M., et al.
Publicado: (2018) -
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial
por: Speers, Corey W., et al.
Publicado: (2023) -
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)
por: Bergqvist, Mattias, et al.
Publicado: (2023)